INTRODUCTION
Development of multidrug resistance is a frequent impediment to the effective treatment of cancer. Although many different mechanisms are involved, multidrug resistance in cultured tumor cells appears most frequently to be associated with increased expression of the ABC transporter proteins, P-glycoprotein (P-gp) and/or Multidrug Resistance Protein (MRP) 1 1 (1-3). As in cells that overexpress P-gp, drug accumulation in cells with elevated levels of MRP1 is reduced, supporting the notion that the multidrug resistance phenotype caused by both of these proteins involves increased drug extrusion (4, 5) . However, in contrast to P-gp, demonstration of MRP1-mediated active transport of unmodified chemotherapeutic drugs such as vincristine and daunorubicin in vitro, using inside-out membrane vesicle systems, requires the presence of GSH in addition to ATP (6) (7) (8) (9) .
More recently, we have shown that stimulation of MRP1 mediated transport by GSH or certain of its analogs is not restricted to unmodified hydrophobic drugs but may also include some organic anion conjugates, such as estrogen sulfates and a glucuronidated tobacco-derived nitrosamine (10, 11) . However, unlike xenobiotics such as vincristine and verapamil (7, 12) , these anionic conjugates appear not to stimulate GSH transport (10, 11) . The mechanisms by which compounds such as vincristine and verapamil stimulate GSH transport remain unclear, although several hypotheses have been proposed (3, 10, 11, 13, 14) .
The most well characterized substrate of MRP1 is the cysteinyl leukotriene, leukotriene C 4 (LTC 4 in an impaired LTC 4 mediated inflammatory response and that mrp1 mediated efflux of LTC 4 is involved in regulating dendritic cell migration to lymph nodes (15, 16) . To date, LTC 4 remains the highest affinity MRP1/mrp1 substrate that has been identified (K m 100 nM) and many MRP1 structure-function studies have been based on LTC 4 transport activity. Examples include reconstitution of LTC 4 transport activity by heterologous coexpression of the NH 2 -and COOH-proximal halves of MRP1 (17) and identification of regions essential or dispensable for function (18) (19) (20) .
Topology studies of MRP1 have revealed that MRP1 and P-gp share a similar core structure consisting of two membrane-spanning domains (MSD2 and MSD3) and two nucleotide-binding domains (NBD1 and NBD2) (21) . The primary distinguishing characteristic of MRP1 and its related proteins, MRPs 2, 3, 6 and 7, is an additional NH 2 -terminal region forming a membrane-spanning domain (MSD1) with five transmembrane helices (1, (21) (22) (23) . This region is linked to the remainder of the protein by a relatively large cytoplasmic loop (CL), designated CL3, of approximately 130 amino acids (21) .
We have shown previously that deletion of MSD1 plus approximately 35 or 95 amino acids of the CL3 eliminates LTC 4 transport activity (18) . However, transport activity could be restored to both NH 2 -terminally truncated proteins by co-expressing a fragment that contains MSD1 and the first 95 amino acids of CL3, but not by a fragment containing MSD1 and only the first 35 amino acids of CL3 (18) . Similarly, an internal deletion of 53 amino acids within CL3 also inactivates the protein. These studies strongly suggest that the physical integrity of a certain portion of CL3 is essential for LTC 4 transport. A similar conclusion was reached by Bakos et al (19) To investigate whether labeling of both half molecules was the consequence of autonomous binding by independent sites in each half of the protein, we examined membranes from cells expressing comparable levels of one or the other fragment.
Although much reduced in intensity, weak photolabeling of the NH 2 -terminal half of the protein could be detected in the absence of the COOH-terminal fragment (Fig. 3B) .
Labeling of the COOH-terminal half was also markedly decreased. However, because of the presence of endogenous proteins with similar electrophoretic mobility to this fragment that were very weakly labeled with [determine whether or not a very low level of binding to the COOH-terminal half of the protein may also occur. Overall, these data demonstrate that high affinity binding of LTC 4 requires association of both halves of the protein and that the NH 2 -proximal half alone may be capable of binding LTC 4 but with much lower affinity than the complete protein.
Co-expression of other combinations of fragments which fail to form a functional transporter, in some cases, displayed labeling on one or two fragments. However, when compared with the results obtained with the full-length protein or by co-expressing fragments MRP1 1-932 with MRP1 932-1531 , the intensity of labeling was in general much reduced (summarized in Table 1 or shown in Fig. 3D ).
[
H]-LTC 4 labeling of tryptic fragments of native MRP1
To confirm that sites in the NH 2 -and COOH-proximal halves of the intact MRP1 expressed in mammalian cells were also labeled with LTC 4 , photolabeling experiments were carried out with membranes prepared from drug resistant H69AR lung cancer cells from which MRP1 was originally cloned (1). We have shown that MRP1 constitutes up to 5% of membrane proteins in these cells (29 
Involvement of cytoplasmic loop 3 in the interaction of MRP1 with LTC 4
We have previously shown that removal of amino acids 1-229 or 1-281 of MRP1, or the region between them, eliminates LTC 4 transport activity (18) . In contrast, coexpression of MRP1 1-281 with either NH 2 -terminally truncated protein or elimination of only amino acids 1-203 results in a transporter that retains 70-80% of the activity of full length MRP1 (18, 19) . Overall, these data indicate that the NH 2 -proximal portion of CL3 between amino acids 203 and 281 contains a region that is essential for transport activity.
To determine whether this region was also required for LTC 4 binding, an array of truncated fragments of MRP1 (see Fig. 1 6B ).
Effects of S-methyl GSH on [ 3 H] LTC 4 labeling of dual halves of MRP1
Because of the ability of GSH to stimulate transport of some MRP1 substrates (6) (7) (8) (9) (10) (11) , it has been proposed that the protein contains a region capable of specific but relatively low affinity binding of free GSH that may interact allosterically with another region capable of binding the 'second' substrate (3, 6, 10, 13) . If such a model is correct, the glutathione moiety of LTC 4 might be expected to interact with the GSH binding region of the protein and that it may be possible to compete for this interaction with free GSH or S-methyl GSH. Consequently, we investigated whether S-methyl GSH competed for binding to either or both half molecules. With concentrations of S-methyl GSH between 0.3-1 mM, a modest but detectable increase in LTC 4 labeling of the COOHterminal half of the protein was observed. However, at 3-10 mM, S-methyl GSH concentration-dependently inhibited labeling, preferentially of the NH 2 -terminal half of the protein (Fig. 7A) During photolabeling studies of MRP1 using AG-A, Ren et al (38) (34) . Thus CL3 appears essential for high affinity binding of substrates that is both GSH dependent and independent, suggesting that it may contain a region that is critical for the correct folding of the protein.
Consequently, confirmation that CL3 forms a GSH binding pocket on the protein will by mutation of conserved lysine residues known to be essential for nucleotide hydrolysis.
In P-gp, such mutations in either NBD completely eliminate transport activity (47 
